Abstract Chronic non-healing wounds are a major health problem with resident bacteria strongly implicated in their impaired healing. A rapid-screen to provide detailed knowledge of wound bacterial populations would therefore be of value and help prevent unnecessary and indiscriminate use of antibiotics-a process associated with promoting antibiotic resistance. We analysed chronic wound fluid samples, which had been assessed for microbial content, using 20 different fluorescent labelled peptide substrates to determine whether protease activity correlated with the bacterial load.
Introduction
Chronic non-healing skin wounds are a major world health problem occurring in three main forms: pressure ulcers, venous leg ulcers and diabetic foot ulcers. These wounds represent an unrecognised cause of disability and distress in the aged population [1] and, importantly, are estimated to consume 2-4% of the total healthcare budget in European Union countries [2, 3] . The incidence of these wounds is rising inexorably with the increased age of the population and corresponding increases in obesity and type II diabetes. These additional comorbidities often result in lower limb amputations and sepsis as frequent chronic wound complications. Uncertainty about the effectiveness of the various wound dressings available [4] highlights the ambiguities involved in the treatment of venous ulcers.
Whilst the aetiology of chronic wounds is multi-factorial, bacteria play an important direct and indirect role in the chronicity of the disease [5] . Through production of proteases and other metabolites, bacteria may both modulate responses in the resident cellular populations and directly degrade extracellular matrix. Additionally, bacteria also stimulate innate and adaptive inflammatory responses in the dermis with the generation of oxidative stress in the wound environment [6] . Wounds support a diverse microflora [7] . The importance of anaerobic organisms in perpetuating wounds has been observed both in vivo [5, 8] and in vitro [6] , although relatively few detailed microbiological studies have been undertaken [9] . Pseudomonas aeruginosa and Staphylococcus aureus are the most frequently isolated aerobic species from these wounds [5, 9] , both species being opportunistic pathogens commonly found colonising healthy skin [10] . Staphylococcus aureus can be highly pathogenic when invading the skin barrier [11] and impairs wound-healing via the expression of a wide range of virulence factors. In the wound environment, the formation of P. aeruginosa biofilms results in significantly larger ulcers and delayed wound-healing [10] and contributes to antibiotic resistance, particularly ciprofloxacin [12] .
Rapid analysis of bacteria populating particular wounds would be extremely useful in clinical practice, avoiding unnecessary and arbitrary use of antibiotics, with its known promotion of antimicrobial resistance [13] . Unfortunately, current microbiological analysis of wound fluid samples takes 48-72 h for aerobic species and over 7 days for slow-growing strictly anaerobic bacteria. Consequently, antibiotic prescribing for these patients is largely empirical with the overprescription of antibiotics [13] and antimicrobial resistance being a common feature in these wounds [9] .
Bacterial enzymes released into the local environment can be measured using well established analytical processes based on chromogenic or fluorogenic substrate assays. Proteases have great potential as specific markers of infection. Novel approaches to infection treatment based on proteases have been extensively researched [14, 15] with the emphasis being on reducing protease activity in the wound using absorbent dressings [16, 17] or protease inhibitors [18, 19] . Bacterial proteases released into the wound environment have a variety of effects on defence and healing mechanisms. These include the activation of matrix metalloproteinases (MMPs) by proteolytic removal of the inhibitory pro-domains [20] , targeting the fibrinolytic system [21] and affecting macrophage activity [22] . Bacterially secreted endoproteases, quantified using fluorescent labelled peptide substrates, can be used for direct identification of specific pathogenic bacteria [23] . Wildeboer et al. [23] showed that protease activity, analysed using short peptide libraries, was most sensitive and specific for the detection and quantification of P. aeruginosa. Hence, characterising protease activity in wound fluid samples, with substrates that specifically detect bacterial proteases, holds potential for a rapid diagnosis.
In the present study, the objective was to identify protease activity against specific peptide substrates that correlated with the bacterial load of wound fluid samples from patients with chronic infected wounds, particularly P. aeruginosa.
Materials and methods

Chemicals and reagents
Chemicals and reagents, if not specified otherwise, were obtained from Sigma-Aldrich (Poole, UK). Peptides were purchased from Sigma-Aldrich, Bachem (St. Helens, UK), Biomol (Exeter, UK) and Calbiochem (Nottingham, UK). Twenty different peptides labeled with a carboxy-terminal 7-amino-4-methylcoumarin (AMC) were included in this study (Table 1) .
Patients
Following local research ethics committee approval and after obtaining patient informed written consent, patients with chronic venous leg ulceration attending the Wound Healing Research Unit, University Hospital of Wales, Cardiff, UK were recruited to provide swab and wound fluid samples. 
Number
Peptide substrate abbreviation
Suc-IIW-AMC
Patients were selected that had highly exudating wounds and included four male and six female patients ( Table 2) . The participant's ages ranged from 62 to 88 years, with a mean age of 74.1±9.2 years and wound duration ranging from 10 months to 27 years. The wounds were all located on the lower legs, with one malleolus wound, four semicircumferential and five circumferential wounds. Ulcer causation was venous disease in five cases, one burn, one trauma and four of unknown aetiology. The patients were receiving a range of medication. Three patients with infected wounds, assessed by experienced wound healing experts, were taking oral antibiotics at the time of wound fluid sampling. Also of note, participant 2 was also using potassium permanganate soaks, a topical treatment effective against Pseudomonas.
Wound fluid samples
Wound fluid from patients was collected using a totally non-invasive method by extracting the fluid from wound dressings [24] . At the same time, a microbiological sample of the wound surface was obtained using Amies charcoal transport swabs (Sterilin, Newport, UK). Dressings and swab samples were transported to the microbiology laboratory where the swab samples were streaked onto non-selective media plates to assess for the presence of bacteria in the wounds. The wound fluid was eluted from the collected dressings no later than 30 min after removal of the dressings from the wound. The dressings were cut into 5 cm×5 cm squares placed in a sterile Petri-dish with 12.5 mL of wound fluid elution buffer (0.1 M Tris-HCl, pH 7.4, 0.1% Triton X-100) and agitated on a tilt board at 4°C for 4 h. The fluid was squeezed out of each dressing using sterile forceps and the eluate of each dressing recombined in a sterile bottle. A 100-μL portion of this fluid was removed for microbial analysis. Wound fluid samples were aliquoted and stored at −80°C in a locked Human Tissue Authority approved freezer.
Microbiological analysis of wound fluid samples
This study focused on bacterial proteases from the two most predominant wound organisms, namely, Pseudomonas aeruginosa and Staphylococcus aureus. Wound fluid samples were extracted from dressings as described above, serially diluted in phosphate buffered saline (137 mM NaCl, 3 mM KCl, 8 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , pH 7.4, PBS) and plated on to selective and non-selective media. A nonselective medium, blood agar (BA, LabM, Bury, UK), was used for culturing the total aerobic population and to obtain a total microbial count for each wound fluid sample. In addition, to ensure that no pseudomonads or staphylococci were missed or overlooked, culture media specifically targeting both organisms were also used. Pseudomonas agar (PA, LabM, Bury, UK) supplemented with 200 mg/L cetrimide and 15 mg/L nalidixic acid was used for detection of P. aeruginosa, and colony identification confirmed by colony morphology, Gram-stain, oxidase and catalase tests as well as PCR. Mannitol salt agar (MSA, Oxoid, Basingstoke, UK) was used for the detection of S. aureus. Staphylococcus aureus grow as yellow colonies on MSA and identity was further confirmed by Gramstain and coagulase tests.
Protein quantification in wound fluid samples
The total protein concentration of the wound fluid samples was quantified using a BCA kit (Novagen-Merck, Darmstadt, Germany) following the standard protocol for the micro-scale assay. The chronic wound fluid samples were diluted 1:5 and 1:20 in Tris-buffered saline (137 mM NaCl, 10 mM Tris-HCl, pH 7.3, TBS) prior to assaying. Absorbance was measured at 584 nm in a micro-plate reader (FLUOstar OPTIMA, BMG Labtech, Offenburg, Germany) and analysed with the accompanying MARS software using a simultaneously recorded bovine serum albumin reference curve. Fluorescent assay of protease activity with peptide-AMC substrates
The fluorescent labelled peptides were selected to cover a range of amino acid sequences specifically recognised by different microbial proteases. Previous work [23] had shown that short fluorescent labelled peptides with varying amino acid sequences can be used to distinguish between proteases originating from different bacterial species. Peptide-AMC substrates were dissolved in DMSO at 5 mg/ml and diluted to 50 μM in PBS. Wound fluid samples were prepared as described above and diluted prior to the assay with an equal volume of Tris buffered saline (137 mM NaCl, 10 mM Tris, pH 7.3, TBS). Aliquots of 10 μl of 50 μM peptide-AMC were pipetted into the wells of a black 96-well micro-titre plate (Greiner, Stonehouse, UK) and 90 μl of wound fluid sample added. The final concentration of substrates in the reaction mix was 5 μM. Fluorescence (excitation wavelength 355 nm, emission wavelength 450 nm) was measured at intervals from the start of the reaction for 12 h following the addition of the wound fluid in a FLUOstar OPTIMA plate reader. Measurements were taken at 5-min intervals for the first 1 h and then every 30 min. Results were corrected for the background fluorescence of the wound fluid sample, as well as for the peptide-AMC.
Results
Microbial status of the wound fluid samples
Pseudomonas aeruginosa was found to be present in all samples bar one, with limited growth seen in sample 1 ( Table 2) . Coagulase negative staphylococci (CNS) were found in six of the samples and S. aureus in five, with samples 3 and 4 containing both organisms. Other organisms detected included Proteus and Corynebacterium spp.
Total protein content of chronic wound fluid samples
The total protein concentration in the wound fluid samples ranged between 873 μg/mL and 510 μg/mL, with a mean of 697 μg/mL and a median of 719 μg/mL ( Table 2 ). The total protein concentration did not correlate with any of the quantitative bacterial counts or protease activity detected with the fluorescent labelled peptides.
Specific protease activity in wound fluid samples
Aliquots from ten chronic wound fluid samples (Table 2) were assayed with each of the peptide-AMC substrates (Table 1) to determine protease activity. Reaction and measurement conditions were optimised for maximum sensitivity and a rapid, but reliable response. Eight substrates out of the 20 tested showed a significant increase in fluorescence over the 12 h reaction time with all or some of the ten wound fluid samples. The slope of the initial linear phase was used to calculate enzyme activity against these eight substrates, as shown for sample numbers 3 and 6 ( Fig. 1) . Figure 2 shows a singlepoint analysis of the fluorescence intensity after 1 h reaction time for all ten wound fluid samples with the eight substrates showing the strongest response. Analysis of protease activities obtained using the peptide-AMC substrates for a relationship with the microbiological data showed a positive correlation for initial enzyme activity, and for 60 min and 6 h signal intensity, with the microbial counts for P. aeruginosa. Scatter plots of all the data indicated that there was no correlation between bacterial count and enzyme activity for most of the substrates. However, Pearson correlation analysis confirmed that enzyme activity measured with two of the 20 peptide-AMC substrates tested (VLK and AFK) were positively correlated with the P. aeruginosa quantitative microbial counts from the ten wound fluid samples (p<0.01, r>0.8, Table 3 ). There was only limited evidence for a moderate relationship between enzyme activity and S. aureus counts, and insufficient evidence for a relationship with total bacterial numbers ( Table 3 ). Regression analysis of the 6-h data, using the AFK substrate with the ten wound fluid samples revealed that enzyme activity against this substrate was a sufficient predictor of the number of P. aeruginosa found in the wound fluid sample (R 2 072%, Fig. 3a) but not for S. aureus (R 2 <35%, Fig. 3b ) or total number of bacteria (Fig. 3c) .
Discussion
Bacterial proteases are a promising target for the analysis of infected wounds [25, 26] with the ultimate aim being to improve patient treatment regimes and overcome the limitations of currently employed antimicrobial therapies, which are often prescribed empirically. Previous work, using purified bacterial proteases and cultivated clinical isolates of P. aeruginosa, has shown that assays with specific peptide substrates can be used to rapidly quantify bacterial pathogens in a given sample [23] . Furthermore, recent identification and characterisation of proteases specific for pathogenic organisms [27, 28] holds possibilities for the development of more specific novel diagnostic approaches as a possible addition to currently employed microbiological and molecular methods. To achieve this goal, assays are required, which allow testing without the need for lengthy purification steps of the patient sample, and which then produce robust and rapid quantitative results. The data presented showed that specific peptide substrates could be used to quantify protease activity in ex vivo Fig. 2 Fluorescence intensity after 60 min reaction time of the wound fluid samples with the eight peptide-AMC substrates that showed the strongest response samples from chronic infected wounds. We also demonstrated that rapid analysis could be directly achieved with these patient wound samples. However, only two of the wide range of peptide substrates screened were identified as having efficacy as specific indicators for the presence of P. aeruginosa in wounds. None proved appropriate for detection of S. aureus. Bacterial proteases play an important role in pathogenicity [29] , and Pseudomonas proteases have been shown to play a significant role in keratitis, affecting both host defence and healing mechanisms [30] . Hence, profiling of protease activity in a wound fluid sample could provide important information on wound healing, particularly if wound proteases were measured over time. This could be achieved with our described method by extraction of the wound fluid and setting up of the fluorescent assay each time a dressing is changed. Furthermore, the identification of species-specific substrates could be the first step to developing specific inhibitory molecules that might limit the pathogenicity of an infecting organism, not only by improving the host's ability to overcome infection but also by promoting wound healing.
A number of the patients included in this study had received various forms of treatment with bactericidal agents. However, five of the ten samples showed P. aeruginosa counts of >1 x 10 6 cfu/mL, with the extracted wound fluid of only one patient being negative for this organism. This implies that P. aeruginosa remained largely unaffected by the antimicrobial treatment regimens being used, highlighting the importance of specifically quantifying and targeting this organism. Previous studies have shown that P. aeruginosa is often under represented by microbial culture, being present in unculturable form [5] . Formation of biofilms by P. aeruginosa in infected wounds delayed healing in a diabetic mouse model [31] , demonstrating the importance of detecting and targeting this organism in wound healing therapy.
Statistical analysis revealed a significant correlation for only two of the 20 substrates tested. The identified substrate, Suc-AFK-AMC, had previously been shown to be a good marker for P. aeruginosa protease activity using cultured reference strains [23] . The second positive substrate, Boc-VLK-AMC, also cleaved the carboxy-terminal of a lysine residue, indicating that this may be a key element in its substrate specificity. Further studies are needed to identify the importance of the remaining peptide amino acids present and to explore the possibility of increasing substrate-specificity by modification of these. Test conditions in this study were optimised in such a way that significant results could be obtained within a 1 h reaction time. Further testing of a larger number of patient samples will be required to confirm these results, and to obtain further insight into the effect that previous patient antimicrobial treatments may have on test outcomes. Our results demonstrate that a rapid test, based on specific enzyme activity, holds exciting potential for identifying pathogenic organisms directly from patient samples such as wound fluid, without the need for time-consuming processing or purification. Such systems could ultimately become useful prognostic indicators of non-healing in the wound healing clinic and hence a significant aid to patient treatment. 
